|
Volumn 5, Issue 5, 2000, Pages 307-317
|
Development and application of a GFP-FRET intracellular caspase assay for drug screening
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAZOLAMIDE;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CASPASE 3;
COMPLEMENTARY DNA;
CYTARABINE;
EMETINE;
ETOPOSIDE;
FAS ANTIGEN;
GREEN FLUORESCENT PROTEIN;
IMMUNOGLOBULIN M;
IMMUNOGLOBULIN M ANTIBODY;
STAUROSPORINE;
THIOMERSAL;
APOPTOSIS;
ARTICLE;
CELL DEATH;
CONTROLLED STUDY;
CYTOLYSIS;
DRUG SCREENING;
ENERGY TRANSFER;
ENZYME ACTIVATION;
ENZYME ASSAY;
FLUORESCENCE;
HUMAN;
HUMAN CELL;
NONHUMAN;
PRIORITY JOURNAL;
TUMOR CELL;
AMINO ACID SEQUENCE;
ANTIBODIES;
ANTIGENS, CD95;
APOPTOSIS;
BIOSENSING TECHNIQUES;
CASPASE 3;
CASPASES;
CYSTEINE PROTEINASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
ENERGY TRANSFER;
ENZYME ACTIVATION;
FLOW CYTOMETRY;
FLUORESCENCE;
GENES, REPORTER;
GREEN FLUORESCENT PROTEINS;
HELA CELLS;
HUMANS;
JURKAT CELLS;
LUMINESCENT PROTEINS;
MOLECULAR SEQUENCE DATA;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RECOMBINANT FUSION PROTEINS;
REPRODUCIBILITY OF RESULTS;
TRANSFECTION;
|
EID: 0033777736
PISSN: 10870571
EISSN: None
Source Type: Journal
DOI: 10.1177/108705710000500502 Document Type: Article |
Times cited : (74)
|
References (25)
|